Plasma branched chain amino acid levels and their respective ketoacid analogues were determined in seven maple syrup urine disease patients ranging in age from 12 h to 12 years. One hundred one pairs were analyzed. There was a high degree of correlation between the amino acid and its ketoacid analogue at every amino acid level. The coefficient of correlation (0.84) was highest for leucine-a-ketoisocaproic acid. The ratio of ketoacid analogue to amino acid, (0.87), was also the greatest for leucine. The close correlation implies that adequate monitoring for therapy can be accomplished by the use of the technically simpler and more rapid determination of the plasma branched chain amino acids.
Maple syrup urine disease (branched chain ketoacidemia) in its classical form is a devastating disease. Untreated, it results in rapid neurologic deterioration and death in the first weeks of life. It is the consequence of a defect in the metabolism of the branched chain amino acids. The first step, transamination, takes place normally, but there is failure of the second step, oxidative decarboxylation. As a result, there is accumulation of both the branched chain amino acids and their ketoacid analogues in a number of body fluids. One of the still unexplained findings in this disease has been the much greater abnormality of the plasma leucine level than that of the other two branched chain amino acids. This is of special importance because the appearance of clinical symptoms can be most closely related to the degree of elevation of the plasma leucine level; we have been able to document this relationship in our treatment of over 20 cases. In addition, study of animal tissue homogenates and brain slices has demonstrated the toxic effect of a-ketoisocaproic acid, the derivative of leucine. Inhibition of 1-glutamic acid decarboxylase (24), depressed oxygen utilization (8), and inhibition of pyruvate oxidation have been reported (1) .
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in this disease because of technical difficulties. We undertook a study of these derivatives in order to determine if these levels could be related to those of the branched chain amino acids in the plasma, and if they might account for the different degree of abnormality of these amino acids.
SUBJECTS AND METHODS
The subjects were seven infants and children with classical maple syrup urine disease as determined by the degree of branched chain amino acid elevation at the time of diagnosis, the degree of enzyme deficiency, and the clinical course. Three were studied in the neonatal period at the time of diagnosis and all were studied when there was biochemical and clinical relapse as a result of an intercurrent infection. The patients ranged in age from 12 h to 12 years at the time of study, and there were four males and three females in the group. Informed consent was obtained from the parents of all the patients.
All plasma amino acid levels were determined with a Beckman RESULTS One hundred one pairs of the branched chain amino acids and their a-keto analogues were determined. There was a definite correlation between the amino acid and its ketoacid analogue at all levels of the amino acid. Leucine levels ranged between 0.7 and 69 mg/dl, isoleucine between 0.1 and 1 1 mg/dl, alloisoleucine between 0.8 and 5.8 mg/dl, and valine between 0.4 and 17.9 mg/dl. a-Ketoisocaproate acid levels were between 0.1 1 and 5 1.6, a-keto-0-methylvaleric acid between 0.1 and 17, and a-ketoisovaleric acid levels between 0.1 and 3.9 mg/dl. The degree of correlation was highest for leucine and a-ketoisocaproate, 0.84, p < 0.0001; it was 0.77, p < 0.0001 for valine and a-ketoisovalerate; and 0.74, p < 0.000 1 for isoleucine, alloisoleucine and aketop-methylvalerate. These results are expressed graphically in figures 1 to 3.
The ratio of ketoacid to amino acid was much higher for leucine than for the other two pairs of amino-ketoacids. The majority of these ratios fell within very narrow limits; 85% of all values were within 1 SD of the mean. The small number of values which lay at either extreme of the range occurred a similar number of times in all subjects.Average ratios, standard deviation, and range are listed in Table 1 . (10) who found that the ketoacid analogues do not accumulate until the level of each branched chain amino acid exceeds 0.8 to 1.0 mM (10.5-13 mg/dl). This conclusion was based on a small number of samples and a technique with poor recoveries of ketoacid analogues in serum, which ranged from 42 to 52%. Our findings do confirm those of Langenbeck et al. (13) who, in a smaller number of subjects and determinations, also found a close correlation between the branched chain amino acids and their corresponding ketoacid analogues.
In every instance, the value for the ketoacid analogue of leucine was the highest and that for the analogue of valine was the lowest. This is similar to the situation with the amino acids where leucine is always the most abnormal, and valine the least abnormal. The plasma branched chain amino acids in 22 infants at the time of diagnosis are summarized in Table 2 and demonstrate these differences quite strikingly. This also occurs whenever biochemical control is lost as a result of an intercurrent infection. These differences in branched chain amino acid accumulation cannot be ascribed to intake. Although there is more leucine then either valine or isoleucine in both cow's and human milk (7), the (23) is much higher than that for the other two branched chain amino acids (21, 22) , and would thus compensate for the differences in intake.
There are several explanations for the lower level of the ketoacid derivative of valine. There is a greater formation of the hydroxy derivative of valine than of the other two amino acids (9) ; the mechanism for this has not yet been determined. The greater renal clearance of this derivative would also tend to lower the plasma concentration (12) . In addition, there are several instances in which there was more residual decarboxylation of this amino acid (4). There is no similar explanation for the much less abnormal level of isoleucine. The combined isoleucinealloisoleucine level is usually only about one-third as abnormal as the leucine level.
There has been a great deal of investigation recently on the mechanism of action of the branched chain a-ketoacid dehydrogenase but none of the findings offers an explanation for the observed differences in amino acid and ketoacid levels. The relative rates of decarboxylation seem to vary with the type of tissue preparation employed. With the use of isolated bovine liver mitochondria (5, 16), perfused rat heart (2), and bovine kidney mitochondria (1 8), a-ketoisovalerate was decarboxylated more rapidly than a-ketoisocaproate. However, when isolated perfused rat liver was used, the rate of a-ketoisocaproate oxidation exceeded that of a-ketoisovalerate decarboxylation at all levels of substrate concentration studied (17) . Coinfusion of either a-ketoisovalerate or of a-keto-P-methylvalerate inhibited the rate of a-ketoisocaproate decarboxylation in both types of tissue preparation. Such inhibition might play a role in the accumulation of a-ketoisocaproate if there were a significant degree of residual enzyme activity. A study utilizing a disrupted cell system obtained from fibroblasts of maple syrup urine disease patients demonstrated a decreased substrate affinity (3); the acitvity of the El component of the dehydrogenase was dependent on the substrate concentration and approached 40 to 60% of normal at 5 mM substrate. This concentration is considerably higher than the highest value observed in this present study. The other two ketoacid analogues were not studied; it is therefore possible that activation might occur at lower concentrations of substrate for these two derivatives. Clearly, much more information is needed about the exact nature of the enzyme deficits in this disorder; the effect of accumulated ketoacids on pyruvate dehydrogenase activity (25) , one component of which may be the same as the Ej component of the branched chain amino acid dehydrogenase, the possibility of acyl-CoA inhibition, and the influence of carnitine on the accumulation of these derivatives (14) are possible directions for further investigation of this disease.
The significantly higher ratio of a-ketoisocaproic acid-leucine than of the other two ketoacid-amino acid pairs is also of some interest. Branched chain amino acid transaminase activity of isolated rat kidney has been increased by perfusion with aketoisocaproate but not with either of the other two branched chain ketoacid analogues (1 5) . This stimulation of transamination by a-ketoisocaproate in addition to any inhibitory effect on decarboxylation by the other two branched chain ketoacid analogues might account for the greater accumulation of the leucine derivative.
The data reported do support the use of plasma levels of branched chain amino acids to monitor the therapy of maple syrup urine disease. The possibility that a-ketoisocaproate is more toxic to the central nervous system than leucine (6, 20) has led to the suggestion that therapy might be improved by monitoring the ketoacids in preference to the amino acids. The close correlation found in this study does imply that adequate monitoring for therapy can be accomplished by the use of the technically simpler and more rapid determination of the plasma branched chain amino acids.
